Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review of the Novel Investigational Antifungal Olorofim
Nathan P. Wiederhold
Journal of Fungi (2020) Vol. 6, Iss. 3, pp. 122-122
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Martin Hoenigl, Rosanne Sprute, Matthias Egger, et al.
Drugs (2021) Vol. 81, Iss. 15, pp. 1703-1729
Open Access | Times Cited: 313
The importance of antimicrobial resistance in medical mycology
Neil A. R. Gow, Carolyn Johnson, Judith Berman, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 152
Aspergillus Infections
George R. Thompson, Jo‐Anne H. Young
New England Journal of Medicine (2021) Vol. 385, Iss. 16, pp. 1496-1509
Closed Access | Times Cited: 117
Emerging Antifungal Targets and Strategies
Marija Ivanov, Ana Ćirić, Dejan Stojković
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2756-2756
Open Access | Times Cited: 98
Coccidioidomycosis: A Contemporary Review
Nancy F. Crum
Infectious Diseases and Therapy (2022) Vol. 11, Iss. 2, pp. 713-742
Open Access | Times Cited: 83
Fungal Drug Response and Antimicrobial Resistance
Paloma Osset-Trénor, Amparo Pascual‐Ahuir, Markus Proft
Journal of Fungi (2023) Vol. 9, Iss. 5, pp. 565-565
Open Access | Times Cited: 47
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 33
Advances in Antifungal Drug Development: An Up-To-Date Mini Review
Ghada Bouz, Martin Doležal
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1312-1312
Open Access | Times Cited: 95
Antifungal drug resistance: an update
David W. Denning
European Journal of Hospital Pharmacy (2022) Vol. 29, Iss. 2, pp. 109-112
Open Access | Times Cited: 66
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective
Frédéric Lamoth, Russell E. Lewis, Dimitrios P. Kontoyiannis
Clinical Infectious Diseases (2022) Vol. 75, Iss. 3, pp. 534-544
Closed Access | Times Cited: 58
Ten decadal advances in fungal biology leading towards human well-being
Ausana Mapook, K. D. Hyde, Khadija Hassan, et al.
Fungal Diversity (2022) Vol. 116, Iss. 1, pp. 547-614
Open Access | Times Cited: 50
Pharmacodynamics, Mechanisms of Action and Resistance, and Spectrum of Activity of New Antifungal Agents
Nathan P. Wiederhold
Journal of Fungi (2022) Vol. 8, Iss. 8, pp. 857-857
Open Access | Times Cited: 42
Antifungals: From Pharmacokinetics to Clinical Practice
Anália do Carmo, Marília João Rocha, Patricia Pereirinha, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 884-884
Open Access | Times Cited: 36
Blastomycosis: A Review of Mycological and Clinical Aspects
Kathleen A. Linder, Carol A. Kauffman, Marisa H. Miceli
Journal of Fungi (2023) Vol. 9, Iss. 1, pp. 117-117
Open Access | Times Cited: 34
Diagnosis, Prognosticators, and Management of Acute Invasive Fungal Rhinosinusitis: Multidisciplinary Consensus Statement and Evidence‐Based Review with Recommendations
Lauren T. Roland, Ian M. Humphreys, Christopher H. Le, et al.
International Forum of Allergy & Rhinology (2023) Vol. 13, Iss. 9, pp. 1615-1714
Open Access | Times Cited: 24
Update on therapeutic approaches for invasive fungal infections in adults
C Boutin, Me‐Linh Luong
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access | Times Cited: 15
Management of drug–drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs
Roger J. M. Brüggemann, Rebecca J. H. M. Verheggen, Emmy Boerrigter, et al.
The Lancet Haematology (2021) Vol. 9, Iss. 1, pp. e58-e72
Closed Access | Times Cited: 48
Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021
Olivia Bupha‐Intr, Coen Butters, Gemma Reynolds, et al.
Internal Medicine Journal (2021) Vol. 51, Iss. S7, pp. 177-219
Open Access | Times Cited: 43
Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance
Jochem B. Buil, Jason D. Oliver, Derek Law, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 703-714
Open Access | Times Cited: 35
Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma
Wilson Lim, Bertrand Nyuykonge, Kimberly Eadie, et al.
PLoS neglected tropical diseases (2022) Vol. 16, Iss. 2, pp. e0010159-e0010159
Open Access | Times Cited: 33
Superficial Dermatophytosis across the World’s Populations: Potential Benefits from Nanocarrier-Based Therapies and Rising Challenges
Puja Keshwania, Narinder Kaur, Jyoti Chauhan, et al.
ACS Omega (2023) Vol. 8, Iss. 35, pp. 31575-31599
Open Access | Times Cited: 21
Diagnosis and Treatment of Pulmonary Coccidioidomycosis and Paracoccidioidomycosis
Paula M. Peçanha‐Pietrobom, Andrés Tirado‐Sánchez, Sarah Santos Gonçalves, et al.
Journal of Fungi (2023) Vol. 9, Iss. 2, pp. 218-218
Open Access | Times Cited: 17
The Role of Olorofim in the Treatment of Filamentous Fungal Infections: A Review of In Vitro and In Vivo Studies
Aliosha Feuss, Marie‐Elisabeth Bougnoux, Éric Dannaoui
Journal of Fungi (2024) Vol. 10, Iss. 5, pp. 345-345
Open Access | Times Cited: 6
The Antifungal Potential of Niclosamide and Structurally Related Salicylanilides
Bernhard Biersack
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5977-5977
Open Access | Times Cited: 6
Antifungal Pipeline
Todd P McCarty, Peter G. Pappas
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top